REPORT HIGHLIGHT
The “Global Cancer Therapeutics Market- – Industry Analysis, Share, Trend, Market Size and Forecast” was estimated to be around US$ 106.8 billion in 2019 and is anticipated to grow with 10.0% of growth rate during the future period.
This report segments the global Cancer Therapeutics Market by types, therapy and geography. This report covers the detailed study of commercially available cancer drugs for geographies such as North America, Europe, Asia Pacific, Meddle East & Africa and South America. Cancer is one of the most prevalent chronic diseases, affecting millions of population worldwide every year. The surge in innovation in cancer treatment and rising demand for cancer related therapeutics has cached attention of many cancer patients to provide effective cancer therapeutics.
Types segment is primarily categorized into prostate cancer, blood cancer, lung cancer, skin cancer, gastrointestinal cancer, breast cancer, and other cancer types. f the different type’s segment, blood cancer, and breast cancer types are accounted for the majority share of the global market revenue. Rise in incidence of blood and breast cancer coupled with increasing demand for novel therapeutics in this segment drives the market growth. However, prostate cancer segment is projected to grow with the highest CAGR of 11.8% during the forecast period.
COVID-19 Impact & Recovery Analysis
The proposed report from AnalystView Market Insights suggests three possible forecast scenarios (probable, optimistic, and pessimistic) considering the COVID-19 impact. Our ongoing research analysis amplifies our framework to ensure the inclusion of underlying COVID-19 crisis impact and potential paths forward. The designed report is delivering detailed insights on COVID-19 considering the changes in consumer demand, purchasing patterns, re-routing of the supply chain, and the significant interventions of governments. The updated study provides insights, and forecast, considering the COVID-19 impact on the market.
Companies reported in this report are: F. Hoffmann-La Roche, Novartis AG, Johnson and Johnson, Pfizer Inc., Sanofi SA, Merck & Co., Inc, GlaxoSmithKline plc, Eli Lilly and Company and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.
The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.
The years considered for the study are:
Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027
The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
The research report categorizes the Cancer Therapeutics Market in each of the following submarkets to forecast the revenues and analyze the trends:
GLOBAL CANCER THERAPEUTICS MARKET, BY TYPES
Prostate Cancer
Blood Cancer
Lung Cancer
Skin Cancer
Gastrointestinal Cancer
Breast Cancer
Others
GLOBAL CANCER THERAPEUTICS MARKET, BY THERAPY
Chemotherapy
Hormonal
Immunotherapy
Targeted Therapy
Others
GLOBAL CANCER THERAPEUTICS MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World